The company held the first half of the board of directors, the board of supervisors
Release time:
2020-07-22
company held the first half of the board of directors and the board of supervisors
semi-annual performance reached a record high
news 8# November 29 , the group company held the 10th board of directors 11 meeting by means of communication, deliberated and passed the "Jianfeng Group 2019 Semi-Annual Report", "On the company's internal control system amendment" and other proposals.
In the first half of the year, the company focused on the general work policy of "innovation and reform, integration and improvement, scientific layout, and steady development " , and focused on the optimization of economic structure and industrial upgrading. Opportunities, continuous internal resource integration, improvement of internal management system, and improvement of enterprise operation efficiency. In the first half of 2019 , the company realized total operating income of 16.86 .9 billion yuan, up 12.17% year-on-year, net profit attributable to owners of the parent company 4.76 .3 billion yuan, up 57.55% year-on-year, and the semi-annual operating performance reached a record high. As of the end of 2019 6 , the company's total assets were 53.83 .1 billion yuan, up 9.82 from the beginning of the year ; Net assets were 38.17 .5 billion yuan, up 10.64 from the beginning of the year .
In the first half of the year, the company made a new breakthrough in the expansion of cement business. The group company completed the acquisition of 100% equity of Guizhou huangpinggu longmingchuan cement co., ltd. and continued to invest in the construction of its new dry cement production line with a daily production of 4500 tons of cement clinker (with waste heat power generation); Yunnan Jianfeng invested ,500 yuan to participate in the establishment of Yunnan Jianfeng Da Zhan Cement Co., Ltd, the company plans to build a cement clinker production line in Mengla County, Xishuangbanna Dai Autonomous Prefecture in accordance with relevant national policies. The company's cement subsidiaries continue to carry out in-depth "three down three improve " activities, steadily implement standardized management, while strictly controlling production costs, and continuously improve labor productivity. Daye Peak, in accordance with the spirit of the Group's standardization year, has implemented standardization of production site management and has achieved good results. Comprehensive treatment of cement packaging dust, hydraulic system of limestone stacker, cement cooling commissioning and other technical renovation projects have been carried out in an orderly manner, all of which have reached good expectations. Yunnan Jianfeng timely grasps the price changes of related products of upstream suppliers through various channels, and strictly controls the procurement cost of raw materials. Concentrate on the development of market share in the core region as a key work, constantly explore and formulate sales strategies suitable for the regional market, effectively improve the market popularity and share of Jianfeng Cement, and achieve the best business performance since it was put into production.
Jianfeng Pharmaceutical continued to increase investment in drug research and development and obtained the Drug Registration Approval for Olopatadine Hydrochloride Eye Drops. In the face of changes in the pharmaceutical sales environment, Spike Pharmaceuticals has integrated its pharmaceutical business and pharmaceutical retail, and strived to extend and expand its third-end market share. Accelerate the consistency evaluation of related drugs, and lay a good foundation for the next step to participate in the centralized procurement of drugs. Jianfeng Pharmaceutical and its subsidiaries continue to increase investment in safety and environmental protection, improve and upgrade various safeguards, and improve the level of automatic control of equipment and facilities; adhere to prevention, improve safety management and three waste treatment capabilities, and effectively reduce environmental protection and safety Production risk. In the first half of the year, Jianfeng Pharmaceutical and its subsidiaries made new progress in a number of technological innovations and engineering constructions. Jianfeng Pharmaceutical's international project of annual production of 20 .7 billion solid preparations has obtained EIA approval and completed civil engineering and bidding for some equipment. Shanghai Beika Drug Approval R & D Laboratory Renovation Project has entered the stage of equipment installation and commissioning. A number of technological transformation projects in Anhui Beika have been carried out in an orderly manner, environmental protection transformation projects such as waste gas (RTO ) and sewage treatment have been put into operation, and the annual output of 1500 tons of acetamiprid powder in pesticide preparation workshop has entered the trial production stage. The laboratory renovation of GMP of Anhui Zhongwang Small Molecule Targeted Drug Research Institute has been basically completed, and the second phase technical renovation project of GMP workshop, including common drugs and small molecule targeted antitumor drugs, has obtained government approval.
The production and operation activities of other business segments of the company are carried out in a standardized and orderly manner.
On the same day, the company also held the rd meeting of the 9th Board of Supervisors and reviewed and approved the relevant report. (Yu fruit)
More information
In the eastern corner of the production area of Jianfeng Health Technology Company, there is a very inconspicuous building. From below, only a few pipes of uneven thickness can be seen on the top and the slogan "Focus on Environmental Protection and Promote Sustainable Development" with red letters on the yellow background on the stainless steel guardrail. Walking up, you can only see several closed pools and a small room with stacks of documents, test tubes, glass bottles and other testing tools on the table. This is the peak and healthy sewage treatment station. The production sewage of the whole factory area is concentrated here. After adjustment (PH adjustment), pre-acidification, anaerobic, anoxic, aerobic (aeration), precipitation and other links, it is discharged into the pipe network after reaching the special discharge standard. Yin Zhiwu, executive deputy general manager of Jianfeng Health, said that because the sewage treatment station in Wucheng District has not yet been built, Jianfeng Health has not yet been able to achieve pipe discharge, and the relevant national laws have strict requirements on the discharge of water pollutants from the extraction pharmaceutical industry. Sewage discharge must reach a special discharge limit, that is, chemical oxygen demand (COD) must be less than 50 mg/L. Enterprise development and environmental protection are both the concept of peak health since its establishment. In March this year, on the basis of the original environmental protection facilities, Jianfeng Health carried out technical renovation of waste gas collection and treatment facilities, and at the same time installed a sealing cover on the sewage treatment station to realize the closed collection of waste gas. Since the trial operation of this facility in mid-May, the overall effect has been obvious. The original treatment tank would emit an unpleasant smell during work, but now the smell has been significantly reduced. Compared with the young enterprise of peak health, the relatively "older" peak pharmaceutical has more experience in sewage treatment and environmental protection. Akihama
2020
07-31
2016 Annual General Meeting of Shareholders
News from our newspaper On May 19, the on-site meeting of Jianfeng Group's 2016 Annual General Meeting of Shareholders was held in Conference Room 314 of Jianfeng Building to deliberate and pass the "2016 Annual Report on the Work of the Board of Directors" and other proposals. The meeting was convened by the board of directors of Jianfeng Group and chaired by Chairman Jiang Xiaomeng. A total of 6 shareholders and proxies attended the meeting, and the total number of voting shares held by them was 55,604,815, accounting for 16.16 of the total voting shares of the company. Some directors, supervisors and secretary of the board of directors of the company attended the meeting, and some senior managers attended the meeting as nonvoting delegates. The meeting was held and voted on by a combination of on-site voting and online voting, it deliberated and passed nine proposals, including the 2016 Work Report of the Board of Directors, the 2016 Work Report of the Board of Supervisors, the 2016 Financial Final Accounts Report, the 2016 Profit Distribution Proposal, the Proposal to Hire the Company's 2017 Audit Institution, the Proposal to Provide Guarantee to Holding Subsidiaries, the 2016 Annual Report and its Summary, the Election of Mr. Huang Sujian as Director of the Company and the Election of Mr. Chen Tianci as Supervisor of the Company. (Zhou Hengbin)
2020
07-31
2016 Annual General Meeting of Shareholders
News from our newspaper On May 19, the on-site meeting of Jianfeng Group's 2016 Annual General Meeting of Shareholders was held in Conference Room 314 of Jianfeng Building to deliberate and pass the "2016 Annual Report on the Work of the Board of Directors" and other proposals. The meeting was convened by the board of directors of Jianfeng Group and chaired by Chairman Jiang Xiaomeng. A total of 6 shareholders and proxies attended the meeting, and the total number of voting shares held by them was 55,604,815, accounting for 16.16 of the total voting shares of the company. Some directors, supervisors and secretary of the board of directors of the company attended the meeting, and some senior managers attended the meeting as nonvoting delegates. The meeting was held and voted on by a combination of on-site voting and online voting, it deliberated and passed nine proposals, including the 2016 Work Report of the Board of Directors, the 2016 Work Report of the Board of Supervisors, the 2016 Financial Final Accounts Report, the 2016 Profit Distribution Proposal, the Proposal to Hire the Company's 2017 Audit Institution, the Proposal to Provide Guarantee to Holding Subsidiaries, the 2016 Annual Report and its Summary, the Election of Mr. Huang Sujian as Director of the Company and the Election of Mr. Chen Tianci as Supervisor of the Company. (Zhou Hengbin)
2020
07-31
2016 Annual General Meeting of Shareholders
News from our newspaper On May 19, the on-site meeting of Jianfeng Group's 2016 Annual General Meeting of Shareholders was held in Conference Room 314 of Jianfeng Building to deliberate and pass the "2016 Annual Report on the Work of the Board of Directors" and other proposals. The meeting was convened by the board of directors of Jianfeng Group and chaired by Chairman Jiang Xiaomeng. A total of 6 shareholders and proxies attended the meeting, and the total number of voting shares held by them was 55,604,815, accounting for 16.16 of the total voting shares of the company. Some directors, supervisors and secretary of the board of directors of the company attended the meeting, and some senior managers attended the meeting as nonvoting delegates. The meeting was held and voted on by a combination of on-site voting and online voting, it deliberated and passed nine proposals, including the 2016 Work Report of the Board of Directors, the 2016 Work Report of the Board of Supervisors, the 2016 Financial Final Accounts Report, the 2016 Profit Distribution Proposal, the Proposal to Hire the Company's 2017 Audit Institution, the Proposal to Provide Guarantee to Holding Subsidiaries, the 2016 Annual Report and its Summary, the Election of Mr. Huang Sujian as Director of the Company and the Election of Mr. Chen Tianci as Supervisor of the Company. (Zhou Hengbin)
2020
07-30
Jianfeng Pharmaceutical Won Advanced Collective of Municipal Red Cross Humanitarian Promotion Award
On April 24, the Red Cross Society of Jinhua issued a circular commending the advanced units and individuals of the 2016 Red Cross Humanitarian Promotion Award. Peak Pharmaceutical Company won the Red Cross Humanitarian Promotion Award for Advanced Collective. The Red Cross is a social relief organization engaged in humanitarian work, with the purpose of carrying forward the spirit of humanity, fraternity and dedication, protecting human life and health, and promoting the cause of peace and progress of mankind. As a socially responsible enterprise, Jianfeng Pharmaceutical has always attached importance to public welfare and charity work, vigorously promoted the spirit of the Red Cross, and vigorously supported the work of the Red Cross with practical actions. In September 2016, at the theme publicity activity of "World First Aid Day" and the opening ceremony of the municipal Red Cross emergency rescue station (point), Huang Jinlong, deputy general manager of the group company and general manager of the pharmaceutical company, donated 6 AEDs known as "life-saving artifact" to the Red Cross on behalf of Jianfeng Pharmaceutical, it is equipped with six Red Cross emergency rescue service stations (points), namely, Jinhua high-speed railway station, sports center, cultural center, Shuanglong scenic spot, Siping village scenic spot and Suoyuan village scenic spot. The configuration of AED equipment has played a very good role in improving the emergency rescue capacity of Jinhua's key locations, and has been affirmed by the Red Cross and related units. (Spike Pharmaceuticals)
2020
07-31
Jingmai Airport Test Flight Successfully Runway Cement Spike Manufacturing
On April 7, a Boeing 737-700 aircraft of China Eastern Airlines Yunnan took off from Kunming. After completing two flight test subjects, it landed safely at Lancang Jingmai Airport. This not only marked the basic completion of the airport flight area, The official start of the test flight also marked that the "Peak" brand airport runway cement passed the first "final exam". Lancang Jingmai Airport is a major project with milestone significance in the history of Pu'er transportation construction. Since then, an air corridor connecting southwest Yunnan and Southeast Asia has been added between Kunming and Pu'er, which will greatly promote the development and utilization of tourism resources in Lancang, Menglian and Ximeng "Pu'er Green Triangle" area, and promote the sustainable development of local economy and society; it is of great significance to strengthen the city's national defense construction, maintain border stability, promote national unity, improve emergency rescue capabilities, and promote Pu'er's integration into the country's "Belt and Road" construction. Since the start of the construction of the airport, Yunnan Jianfeng has been paying close attention to it, organizing technical research and repeated tests, and finally produced high-quality airport runway special cement, and with excellent product quality, superior product performance and high-quality service, it has become a runway for Lancang Airport. Cement manufacturer. This not only fills the gap of "peak" airport special cement, but also is of great significance to promote the "peak" brand and improve the market influence of enterprises. It is understood that Jingmai Airport is initially confirmed to be officially opened to traffic at the end of May. (Li Liangping)
2020
07-31
Contact Us
No. 88 Wujiang East Road, Jinhua City, Zhejiang Province, China
Tel: +86-579-82326868
Fax : +86-579-82324666
©2023 Zhejiang Jianfeng Group Co., Ltd. Powered by: www.300.cn SEO Business License
SAF Coolest v1.2 设置面板 SHJSS-AHDB-FSSQE-ZSW
无数据提示
Sorry, the current column has no content !
You can view other columns or return to Home Page